✦ LIBER ✦

Monotherapy with the calcium channel antagonist nisoldipine for systemic hypertension and comparison with diuretic drugs

✍ Scribed by Andre R. Daniels; Lionel H. Opie

Book ID: 113114433
Publisher: Elsevier Science
Year: 1987
Tongue: English
Weight: 571 KB
Volume: 60
Category: Article
ISSN: 0002-9149
DOI: 10.1016/0002-9149(87)90386-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of efficacy and side effects

Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension

✍ Franz H Messerli; Suzanne Oparil; Zhanbin Feng 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 293 KB

Antihypertensive drugs and glucose metab

Antihypertensive drugs and glucose metabolism: comparison between a diuretic, a beta-blocker and felodipine, a new calcium antagonist in subjects with arterial hypertension and diabetes

✍ H. LUNDGREN; C. BENGTSSON; L. LAPIDUS; L. BENGTSSON 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 460 KB

Comparison of the effects of angiotensin

Comparison of the effects of angiotensin II receptor antagonist monotherapy and combination therapy with a diuretic on cardiac function in spontaneously hypertensive rats

✍ Masuda, Kasumi; Taenaka, Hiroki; Asanuma, Toshihiko; Nakatani, Satoshi 📂 Article 📅 2012 🏛 Japan Science and Technology Information Aggregato 🌐 English ⚖ 649 KB

Comparison of valsartan 160 mg with lisi

Comparison of valsartan 160 mg with lisinopril 20 mg, given as monotherapy or in combination with a diuretic, for the treatment of hypertension: The blood pressure reduction and tolerability of valsartan in comparison with lisinopril (PREVAIL) study

✍ Ettore Malacco; Massimo Santonastaso; Natale A. Varì; Anna Gargiulo; Vitaliano S 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 835 KB

Interim evidence of the renoprotective e

Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study

✍ Yasuhiko Iino; Matsuhiko Hayashi; Tetsuya Kawamura; Tatsuo Shiigai; Yasuhiko Tom 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 613 KB